Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000428835 | SCV000522916 | benign | not specified | 2016-12-15 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000538249 | SCV000639593 | benign | ALG2-congenital disorder of glycosylation; Congenital myasthenic syndrome 14 | 2024-01-30 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000538249 | SCV002802523 | likely benign | ALG2-congenital disorder of glycosylation; Congenital myasthenic syndrome 14 | 2022-03-10 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV003480628 | SCV004225059 | uncertain significance | not provided | 2023-06-22 | criteria provided, single submitter | clinical testing | BS1 |